Frontiers | Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation - ScienceDirect
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor - ScienceDirect
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor